Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.
Also called NCT01626534
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 125 participants
- Registry
-
NCT01626534
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT01626534. Randomized; no masking; primary purpose treatment. Start 2012-03 (registry gives no type); primary completion 2014-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- trigagrelor
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
Record details
- Record id
cardio:ct-nct01626534- Content hash
1abf4d0705f52442a3f9e6711d3d101f25ae0dee816d8accaaa027115f946b8c